SHANGHAI, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its wholly owned subsidiary, Growing Bioengineering Company Limited, will attend a premier natural and health products trade show in Anaheim, California, in March 2011.
A senior R&D officer and other business executives from the Company will present at the Natural Products Expo West in Anaheim, California. Having attracted approximately 3,400 exhibitors and 50,000 spectators in 2010, Expo West is the world's largest natural, organic and healthy products trade show. This annual exhibition is hosted by New Hope Natural Media and has been ongoing since 1981. A wide array of industry participants including wholesalers, distributors, chain store owners and R&D professionals are expected to attend this year's event from Friday, March 11th to Sunday, March 13th at the Anaheim Convention Center.
Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "As an important aspect of the expanding global health products market, bulk probiotics products continues to grow rapidly in core areas such as dairy and animal feed while finding more applications in new areas such as food, beverage and cosmetics. We will continue to participate in more global industry events to gain insights into the latest industry trends and technological developments as well as to help promote our brand to a global audience. We are confident that the enhanced safety and stability of our bulk products are allowing us to venture into new market areas such as baby care products and eventually new domestic and overseas geographic markets as well."
China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.
Chief Financial Officer
Shiwei Yin/Dixon Chen
SOURCE China-Biotics, Inc.